Bladder Cancer Clinical Trials in Iowa City, Iowa

4 studies are recruiting for bladder cancer in Iowa City, Iowa right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2

    Bladder cancer is the most common urinary tract cancer and the 6th most common cancer in the US. Yet bladder cancer research is underfunded relative to other common cancers. As a result, bladder cancer care is prone to evidence gaps that produce decision uncertainty for both patients and clinicians…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Iowa, Iowa City, Iowa
    Locations
    6 in total
    Run by
    University of Washington

    See if you can join NCT07225127 on ClinicalTrials.gov

  2. Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

    The goal of this clinical trial is to learn whether a combination of two chemotherapy drugs, Gemcitabine and Docetaxel, can treat high-grade non-muscle-invasive bladder cancer (HG-NMIBC) in adults whose cancer failed conventional BCG therapy. The drugs are given directly into the bladder (intravesi…

    Stage
    Phase 2
    Ages
    18 to 99
    Site
    University of Iowa, Iowa City, Iowa
    Run by
    Michael A. O'Donnell

    See if you can join NCT07322263 on ClinicalTrials.gov

  3. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinical impact on pts with advanced cancer to facilitate clinical…

    Stage
    Not phased
    Ages
    Any age
    Site
    Massive Bio SYNERGY-AI site, Iowa City, Iowa
    Locations
    68 in total
    Run by
    Massive Bio, Inc.

    See if you can join NCT03452774 on ClinicalTrials.gov

  4. Intravenous Ascorbate Plus Gemcitabine/Carboplatin: A Novel and Cost-Effective Alternative With Evident Efficacy in Patients With Muscle Invasive Bladder Cancer

    This is a phase II, single arm, Simon two-stage design, trial, enrolling patients with cisplatin ineligible MIBC and/or those patients who decline cisplatin based NAC. Assess rates of pathologic downstaging and quality of life in MIBC cisplatin-ineligible/declined patients when IVC is added to gemc…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Holden Comprehensive Cancer Center - The University of Iowa, Iowa City, Iowa
    Locations
    2 in total
    Run by
    University of Kansas Medical Center

    See if you can join NCT06493370 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.